Samsung Biologics

Total 1 Post
Samsung Biologics is a Korea-based company, which manufactures bio-healthcare products and develops and distributes biopharmaceutical products.

Samsung Biologics Won a $360 Million Contract for the Production of COVID-19 Vaccine

The total amount of the contract is $360 million. Samsung Biologics will start producing drugs for treating coronavirus infection COVID-19 once Vir Biotechnology completes its development.

Don't miss the next top notch things!

We know they're worth it. Like or website to enjoy them night and day.